Skip to main content

Advertisement

Table 4 Sensitivity analysis testing the probability that screening participation or invitation-to-screening is cost-effective

From: Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy

  INMB Probability cost-effective
WTP (€ per QALY) 30,000 WTP (€ per QALY) 50,000 WTP (€ per QALY) 30,000 WTP (€ per QALY) 50,000
Screening participation (group P vs. group C)
 Base-case 368 959 0.79 0.89
 High prob of LC (p LC  = 6.79 %) 609 1376 0.86 0.92
 Low prob of LC (p LC  = 4.2 %) 160 600 0.67 0.84
 Alternative QoL 134 568 0.63 0.80
 Higher costs 265 856 0.72 0.87
Invitation-to-screening (group I vs. group C)
 Base-case 365 692 0.95 0.97
 High prob of LC (p LC  = 4.73 %) 438 816 0.96 0.97
 Low prob of LC (p LC  = 3.68 %) 311 601 0.94 0.97
 Alternative QoL 260 519 0.90 0.93
 Higher costs 339 667 0.94 0.96
  1. INMB incremental net monetary benefit, WTP willingness to pay, LC lung cancer